Improving anticoagulation therapy using point-of-care testing and a standardized protocol
CA Franke, LM Dickerson… - The Annals of Family …, 2008 - Annals Family Med
PURPOSE Many patients in primary care require anticoagulation with warfarin for the
prevention of venous and systemic embolism. Achieving the goal international normalized ratio (…
prevention of venous and systemic embolism. Achieving the goal international normalized ratio (…
[PDF][PDF] Genomic dissection of bipolar disorder and schizophrenia, including 28 subphenotypes
…, M Flickinger, TM Foroud, L Forty, J Frank, L Franke… - Cell, 2018 - cell.com
Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology.
Understanding the genetic factors contributing to the shared and disorder-specific symptoms …
Understanding the genetic factors contributing to the shared and disorder-specific symptoms …
[PDF][PDF] Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases
…, AH Fanous, MS Farrell, J Frank, L Franke… - The American Journal of …, 2014 - cell.com
Regulatory and coding variants are known to be enriched with associations identified by
genome-wide association studies (GWASs) of complex disease, but their contributions to trait …
genome-wide association studies (GWASs) of complex disease, but their contributions to trait …
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find
associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced …
associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced …
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
Copy number variants (CNVs) have been strongly implicated in the genetic etiology of
schizophrenia (SCZ). However, genome-wide investigation of the contribution of CNV to risk has …
schizophrenia (SCZ). However, genome-wide investigation of the contribution of CNV to risk has …
[PDF][PDF] Modeling linkage disequilibrium increases accuracy of polygenic risk scores
…, AH Fanous, MS Farrell, J Frank, L Franke… - The american journal of …, 2015 - cell.com
Polygenic risk scores have shown great promise in predicting complex disease risk and will
become more accurate as training sample sizes increase. The standard approach for …
become more accurate as training sample sizes increase. The standard approach for …
Sex-dependent shared and nonshared genetic architecture across mood and psychotic disorders
…, L Essioux, AH Fanous, MS Farrell, J Frank, L Franke… - Biological …, 2022 - Elsevier
Background Sex differences in incidence and/or presentation of schizophrenia (SCZ), major
depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for …
depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for …
[PDF][PDF] Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder
…, E Fombonne, T Foroud, J Frank, B Franke… - The American Journal of …, 2015 - cell.com
Genetic risk prediction has several potential applications in medical research and clinical
practice and could be used, for example, to stratify a heterogeneous population of patients by …
practice and could be used, for example, to stratify a heterogeneous population of patients by …
[PDF][PDF] Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood
…, AH Fanous, MS Farrell, J Frank, L Franke… - The American Journal of …, 2018 - cell.com
Genetic correlation is a key population parameter that describes the shared genetic architecture
of complex traits and diseases. It can be estimated by current state-of-art methods, ie, …
of complex traits and diseases. It can be estimated by current state-of-art methods, ie, …
Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia
Importance About 20% to 30% of people with schizophrenia have psychotic symptoms that
do not respond adequately to first-line antipsychotic treatment. This clinical presentation, …
do not respond adequately to first-line antipsychotic treatment. This clinical presentation, …